Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Stratec SE

Market Cap 22Cr 26Cr 21Cr 19Cr 37Cr 2.46TCr 37Cr 245.02Cr 95Cr 1.21TCr 98Cr 96Cr 4.18TCr P/E 2026 *
18x
P/E 2027 * 12.3x
Enterprise Value 33Cr 38Cr 30Cr 28Cr 53Cr 3.56TCr 53Cr 354.62Cr 138.06Cr 1.75TCr 141.6Cr 138.57Cr 6.05TCr EV / Sales 2026 *
1.22x
EV / Sales 2027 * 1.14x
Free-Float
49.38%
Yield 2026 *
3.63%
Yield 2027 * 4.18%
Manager TitleAgeSince
Chief Executive Officer 58 01/04/2011
Director of Finance/CFO 38 01/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 29/05/2019
Director/Board Member 73 21/07/2020
Chairman 68 20/05/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26Cr
-1.48%-4.33%+18.18%-12.55% 18TCr
-1.96%-2.53%-21.58%+22.50% 15TCr
-0.74%-3.34%-9.32%-24.98% 13TCr
-4.33%-6.86%-55.74%-16.68% 6.97TCr
-1.78%+0.48%+17.91%-6.01% 5.1TCr
-1.84%-1.28%-24.46%-33.85% 4.57TCr
-4.94%-5.65%+6.97%+5.09% 3.62TCr
-0.52%-1.87%+4.48%+35.37% 3.54TCr
-1.79%-4.25%-14.18%-22.62% 2.88TCr
Average -1.93%-2.78%-8.64%-5.97% 7.98TCr
Weighted average by Cap. -1.95%-3.05%-7.35%-6.01%

Financials

2026 *2027 *
Net sales 27Cr 31Cr 25Cr 23Cr 43Cr 2.92TCr 44Cr 291.05Cr 113.31Cr 1.43TCr 116.22Cr 113.73Cr 4.96TCr 28Cr 33Cr 26Cr 25Cr 46Cr 3.11TCr 47Cr 309.29Cr 120.41Cr 1.52TCr 123.5Cr 120.86Cr 5.27TCr
Net income 1.4Cr 1.63Cr 1.29Cr 1.21Cr 2.28Cr 153.4Cr 2.3Cr 15Cr 5.95Cr 75Cr 6.1Cr 5.97Cr 260.44Cr 1.83Cr 2.12Cr 1.68Cr 1.58Cr 2.97Cr 200.03Cr 3Cr 20Cr 7.76Cr 98Cr 7.96Cr 7.79Cr 339.62Cr
Net Debt 10Cr 12Cr 9.25Cr 8.7Cr 16Cr 1.1TCr 16Cr 109.6Cr 43Cr 540.08Cr 44Cr 43Cr 1.87TCr 9.77Cr 11Cr 8.98Cr 8.45Cr 16Cr 1.07TCr 16Cr 106.45Cr 41Cr 524.53Cr 43Cr 42Cr 1.81TCr
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
1,395
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.50EUR
Average target price
25.40EUR
Spread / Average Target
+37.30%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!